Subscribe to Smart Business Dealmakers
August 5, 2022
Evaluating your sell-side options in an exit
By Adam Burroughs
RiverGlade Capital's Kevin McGrath, Council Capital's Nick Cooper, Pinnacle Financial Partners' Tyler Morgan, Capital Alignment Partners' John Pontius, Whistler Capital's Darshan Prabhu and Bass, Berry & Sims' Tatjana Paterno discuss what goes into a successful exit beyond a liquidity event, including when a private equity firm sells one of its portfolio companies.
June 10, 2022
How Reps & Warranties Is Increasing Deal Efficiency
Waller Lansden Dortch & Davis' Tyson Bickley, LFM Capital's Chris Lin, Resource Label Group's Hunter Rost and LBMC's Brian Marynowitz on how to evolve your buy-side strategies in 2022 and beyond, and key mistakes you can avoid.
October 8, 2021
How family alignment helped Monticeto Medical Real Estate reach its BHAG
Monticeto Medical Real Estate CEO Chip Conk, along with Bass, Berry & Sims’ Frank Pellegrino and EY's Bobby Stover explore dealmaking, growth and communication within a family business.
September 9, 2021
Chris Chandler on Radio Systems Corp.’s patient seller approach
Radio Systems Corp.' Chris Chandler on how the company was able to use past experience to maximize value when the company was sold.
August 19, 2021
Sehrish Siddiqui talks ESG and private deals
Sehrish Siddiqui, Corporate and Securities Partner at Bass, Berry & Sims talks about how ESG matters have started to work their way from the public sphere and into private deal diligence.
July 16, 2021
Brian Fox on the sale of Confirmation to Thomson Reuters
Brian Fox, the founder and now former president of Confirmation, says his company had been on not just Thomson Reuters' radar screen, but many of the big players in the in the tax and accounting space.
January 17, 2020
Tammy Wolcott: Time kills deals, so move fast
W Squared co-founder Tammy Wolcott talks about how she and her team prepared the business for a sale.
January 3, 2020
For Arnie Malham, Selling One Business Informs Growing The Next
Arnie Malham had a nice little business in MedView Services, but it wasn’t really sellable. “What we found out is that while we had a great little niche with great little margins, the upside wasn't big.
